Foghorn Therapeutics vs Tango Therapeutics
FHTX and TNGX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FHTX and TNGX compare
Tango Therapeutics is the larger company, worth 34 times as much as Foghorn Therapeutics ($4.2B against $122M).
Foghorn Therapeutics grew revenue faster over the last twelve months (357% versus −100% for Tango Therapeutics).
Foghorn Therapeutics scores higher on the StockData Score (11 against 8 for Tango Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FHTX | TNGX |
|---|---|---|
| Size and price | ||
| Market cap | $122M | $4.2B |
| Share price | $2.05 | $24.85 |
| Change, 1 year | −53.8% | 197% |
| Change, 5 years | −85.0% | 108% |
| Beta (5Y) | 1.87 | 1.18 |
| Employees | 106 | 137 |
| StockData Score | ||
| Total score | 11 (better) | 8 |
| Valuation score | 2 (better) | 0 |
| Growth score | 2 (better) | 1 |
| Performance score | 2 (better) | 1 |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 29.3× | – |
| P/S | 1.1× | – |
| P/B | – | 4.3× |
| EV/EBITDA | 10.8× | – |
| FCF yield | −68.7% | −3.6% (better) |
| Fair value | $2.07 | – |
| Margin of safety | 1.1% | – |
| Growth | ||
| Revenue growth (TTM) | 357% (better) | −100% |
| Revenue growth, 5Y average | 135% (better) | 52.1% |
| Profitability | ||
| Operating margin | 2.1% | – |
| Net margin | 8.4% | – |
| FCF margin | −74.6% | – |
| Return on equity | – | −36.5% |
| Return on invested capital | – | −3646% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Current ratio | 4.24 | 39.45 (better) |
| Altman Z-score | −2.66 | 46.53 (better) |
| Piotroski F-score | 2 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 75.6% | 127% |
| Held by insiders | 36.3% | 11.7% |
| Insider net buying, 12 months | – | −$8.0M |
| Short interest, % of float | 6.0% | 32.4% |
Go deeper
- FHTX stock overview
- FHTX income statement
- FHTX valuation and score
- TNGX stock overview
- TNGX income statement
- TNGX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.